Story perspectives

FDA Introduces Quarterly Bonuses to Boost Drug Reviews

2/26/2026

Summary

Story summary

Bloomberg News reports that the U.S. Food and Drug Administration (FDA) plans quarterly bonuses for scientific staff to accelerate drug reviews, with staff earning several thousand dollars per quarter.
The initiative begins on April 1 and follows the Commissioner's National Priority Voucher program to speed FDA decisions on critical drugs.
The FDA is hiring more than 1,000 new scientists to enhance drug evaluations.
First bonus payments are expected in August.

1 of 1

Story summary

Bloomberg News reports that the U.S. Food and Drug Administration (FDA) plans quarterly bonuses for scientific staff to accelerate drug reviews, with staff earning several thousand dollars per quarter.
The initiative begins on April 1 and follows the Commissioner's National Priority Voucher program to speed FDA decisions on critical drugs.
The FDA is hiring more than 1,000 new scientists to enhance drug evaluations.
First bonus payments are expected in August.